Literature DB >> 24595473

Pseudomonas aeruginosa reduces the expression of CFTR via post-translational modification of NHERF1.

Rosa Rubino1, Valentino Bezzerri, Maria Favia, Marcella Facchini, Maela Tebon, Anurag Kumar Singh, Brigitte Riederer, Ursula Seidler, Antonio Iannucci, Alessandra Bragonzi, Giulio Cabrini, Stephan J Reshkin, Anna Tamanini.   

Abstract

Pseudomonas aeruginosa infections of the airway cells decrease apical expression of both wild-type (wt) and F508del CFTR through the inhibition of apical endocytic recycling. CFTR endocytic recycling is known to be regulated by its interaction with PDZ domain containing proteins. Recent work has shown that the PDZ domain scaffolding protein NHERF1 finely regulates both wt and F508delCFTR membrane recycling. Here, we investigated the effect of P. aeruginosa infection on NHERF1 post-translational modifications and how this affects CFTR expression in bronchial epithelial cells and in murine lung. Both in vitro in bronchial cells, and in vivo in mice, infection reduced CFTR expression and increased NHERF1 molecular weight through its hyper-phosphorylation and ubquitination as a consequence of both bacterial pilin- and flagellin-mediated host-cell interaction. The ability of P. aeruginosa to down-regulate mature CFTR expression was reduced both in vivo in NHERF1 knockout mice and in vitro after silencing NHERF1 expression or mutations blocking its phosphorylation at serines 279 and 301. These studies provide the first evidence that NHERF1 phosphorylation may negatively regulate its action and, therefore, the assembly and function of multiprotein NHERF1 complexes in response to infection. The identification of molecular mechanisms responsible for these effects could identify novel targets to block potential P. aeruginosa interference with the efficacy of potentiator and/or corrector compounds.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24595473     DOI: 10.1007/s00424-014-1474-6

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  37 in total

1.  Knockdown of NHERF1 enhances degradation of temperature rescued DeltaF508 CFTR from the cell surface of human airway cells.

Authors:  Sang-Ho Kwon; Harvey Pollard; William B Guggino
Journal:  Cell Physiol Biochem       Date:  2007

Review 2.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

3.  Mitogen-activated protein kinase phosphatase 2, MKP-2, regulates early inflammation in acute lung injury.

Authors:  Timothy T Cornell; Andrew Fleszar; Walker McHugh; Neal B Blatt; Ann Marie Le Vine; Thomas P Shanley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-08       Impact factor: 5.464

4.  Phosphorylation and cell cycle-dependent regulation of Na+/H+ exchanger regulatory factor-1 by Cdc2 kinase.

Authors:  J He; A G Lau; M B Yaffe; R A Hall
Journal:  J Biol Chem       Date:  2001-08-30       Impact factor: 5.157

5.  PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator.

Authors:  Agnieszka Swiatecka-Urban; Marc Duhaime; Bonita Coutermarsh; Katherine H Karlson; James Collawn; Michal Milewski; Garry R Cutting; William B Guggino; George Langford; Bruce A Stanton
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

6.  Anti-inflammatory effect of miglustat in bronchial epithelial cells.

Authors:  Maria Cristina Dechecchi; Elena Nicolis; Caroline Norez; Valentino Bezzerri; Monica Borgatti; Irene Mancini; Paolo Rizzotti; Carla M P Ribeiro; Roberto Gambari; Frederic Becq; Giulio Cabrini
Journal:  J Cyst Fibros       Date:  2008-09-23       Impact factor: 5.482

7.  Na+/H+ exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o- cells.

Authors:  Maria Favia; Lorenzo Guerra; Teresa Fanelli; Rosa Angela Cardone; Stefania Monterisi; Francesca Di Sole; Stefano Castellani; Mingmin Chen; Ursula Seidler; Stephan Joel Reshkin; Massimo Conese; Valeria Casavola
Journal:  Mol Biol Cell       Date:  2009-11-04       Impact factor: 4.138

8.  A kinase-regulated mechanism controls CFTR channel gating by disrupting bivalent PDZ domain interactions.

Authors:  Viswanathan Raghuram; Hayley Hormuth; J Kevin Foskett
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

9.  Phosphorylation of PDZ1 domain attenuates NHERF-1 binding to cellular targets.

Authors:  James W Voltz; Matthew Brush; Suzanne Sikes; Deborah Steplock; Edward J Weinman; Shirish Shenolikar
Journal:  J Biol Chem       Date:  2007-09-25       Impact factor: 5.157

10.  A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system.

Authors:  Jennifer M Bomberger; Siying Ye; Daniel P Maceachran; Katja Koeppen; Roxanna L Barnaby; George A O'Toole; Bruce A Stanton
Journal:  PLoS Pathog       Date:  2011-03-24       Impact factor: 6.823

View more
  8 in total

Review 1.  Innovative Therapies for Cystic Fibrosis: The Road from Treatment to Cure.

Authors:  Giulio Cabrini
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

2.  Parathyroid hormone initiates dynamic NHERF1 phosphorylation cycling and conformational changes that regulate NPT2A-dependent phosphate transport.

Authors:  Qiangmin Zhang; Kunhong Xiao; José M Paredes; Tatyana Mamonova; W Bruce Sneddon; Hongda Liu; Dawei Wang; Sheng Li; Jennifer C McGarvey; David Uehling; Rima Al-Awar; Babu Joseph; Frederic Jean-Alphonse; Angel Orte; Peter A Friedman
Journal:  J Biol Chem       Date:  2019-01-29       Impact factor: 5.157

Review 3.  Effects of Pseudomonas aeruginosa on CFTR chloride secretion and the host immune response.

Authors:  Bruce A Stanton
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-25       Impact factor: 4.249

4.  Rational Design of Potent and Selective Inhibitors of an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa.

Authors:  Seiya Kitamura; Kelli L Hvorecny; Jun Niu; Bruce D Hammock; Dean R Madden; Christophe Morisseau
Journal:  J Med Chem       Date:  2016-05-04       Impact factor: 7.446

Review 5.  Molecular basis of cystic fibrosis: from bench to bedside.

Authors:  Maria Cristina Dechecchi; Anna Tamanini; Giulio Cabrini
Journal:  Ann Transl Med       Date:  2018-09

6.  Quorum Sensing Down-Regulation Counteracts the Negative Impact of Pseudomonas aeruginosa on CFTR Channel Expression, Function and Rescue in Human Airway Epithelial Cells.

Authors:  Émilie Maillé; Manon Ruffin; Damien Adam; Hatem Messaoud; Shantelle L Lafayette; Geoffrey McKay; Dao Nguyen; Emmanuelle Brochiero
Journal:  Front Cell Infect Microbiol       Date:  2017-11-10       Impact factor: 5.293

7.  Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis.

Authors:  Alessandro Rimessi; Chiara Pozzato; Lorenzo Carparelli; Alice Rossi; Serena Ranucci; Ida De Fino; Cristina Cigana; Anna Talarico; Mariusz R Wieckowski; Carla M P Ribeiro; Claudio Trapella; Giacomo Rossi; Giulio Cabrini; Alessandra Bragonzi; Paolo Pinton
Journal:  Sci Adv       Date:  2020-05-06       Impact factor: 14.136

8.  Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles.

Authors:  Katja Koeppen; Roxanna Barnaby; Angelyca A Jackson; Scott A Gerber; Deborah A Hogan; Bruce A Stanton
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.